Abstract:In patients with synucleinopathies, the protein α-synuclein misfolds into multiple conformations, each of which determines whether a patient develops multiple system atrophy (MSA) or one of three Lewy body diseases (LBDs). However, patients may also first present with pure autonomic failure, which strictly impacts autonomic nerves in the periphery, which can then phenoconvert into MSA or a LBD. When neuroinvasion happens, it remains unknown if strain properties are retained or if strain adaptation occurs, even though neuroinvasion of some prion protein (PrP) strains is known to result in the emergence of novel PrP strain variants. To investigate this question in synucleinopathies, we inoculated TgM83 +/- mice, which express human α-synuclein with the A53T mutation, with a mouse-passaged MSA patient sample either intracranially (i.c.) or into the sciatic nerve (sc.n.), and compared the biochemical and biological properties of α-synuclein prions in the brains of terminal mice. Importantly, while i.c. and sc.n. transmission studies generated pathogenic α-synuclein with similar properties, both the primary and secondary passaged MSA samples had different infectivity profiles in a panel of α-syn140-YFP cells than the starting MSA patient sample, indicating that MSA prions adapt during initial passage in TgM83 +/- mice. Similarly, using i.c. inoculation of A53T preformed fibrils to study strain selection, we found both biochemical and biological evidence that mouse passage exerts a selective pressure on α-synuclein prions in which a sub-population of starting conformations emerges in terminal animals. Together, these findings demonstrate that similar conformational selective pressures known to impact PrP prion replication also impact replication of α-synuclein prions. The protein α-synuclein can misfold into multiple shapes that self-template (i.e., becomes a prion) to cause a group of neurodegenerative disorders known as synucleinopathies. The misfolded shape that α-synuclein adopts, or prion strain, determines the disorder a patient will develop. While the selective pressures that impact this same phenomenon in classical prion diseases, which are caused by misfolding of the prion protein, have been the focus of research for several decades, little is known about the effect of strain adaptation and/or selection on α-synuclein prion strains. The studies reported here demonstrate that both conformational selective pressures impact α-synuclein prion replication, which has important consequences for diagnostic and therapeutic development.

A New Cell Model for Investigating Prion Strain Selection and Adaptation

Infection of Prions and Treatment of PrP106–126 Alter the Endogenous Status of Protein 14-3-3 and Trigger the Mitochondrial Apoptosis Possibly via Activating Bax Pathway

Species barrier as molecular basis for adaptation of synthetic prions with N‐terminally truncated PrP

A-synuclein prion strains differentially adapt after passage in mice

Protein Misfolding Cyclic Amplification Cross-Species Products of Mouse-Adapted Scrapie Strain 139A and Hamster-Adapted Scrapie Strain 263K with Brain and Muscle Tissues of Opposite Animals Generate Infectious Prions

Strain-Specific Targeting and Destruction of Cells by Prions

Minor prion substrains overcome transmission barriers

Prion Protein Deficiency Causes Diverse Proteome Shifts in Cell Models That Escape Detection in Brain Tissue

Probing the origin of prion protein misfolding via reconstruction of ancestral proteins

Multiple steps of prion strain adaptation to a new host

PrP(Sc) of Scrapie 263K Propagates Efficiently in Spleen and Muscle Tissues with Protein Misfolding Cyclic Amplification.

Prion propagation in cells expressing PrP glycosylation mutants

Selective neuronal targeting in prion disease

Environmental and host factors that contribute to prion strain evolution

Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation

A multiverse of α-synuclein: investigation of prion strain properties with carboxyl-terminal truncation specific antibodies in animal models

Understanding Intra-Species and Inter-Species Prion Conversion and Zoonotic Potential Using Protein Misfolding Cyclic Amplification

Cerebellar compartmentation of prion pathogenesis

Adaptive selection of a prion strain conformer corresponding to established North American CWD during propagation of novel emergent Norwegian strains in mice expressing elk or deer prion protein

The Molecular Determinants of a Universal Prion Acceptor